Glibenclamide improves kidney and heart structure and function in the adenine-diet model of chronic kidney disease

Pharmacological Research

Volumn 79, Issue , 2014, Pages 104-110

  Diwan, Vishal ^a   Gobe, Glenda ^a   Brown, Lindsay ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

Author keywords

Adenine; Glibenclamide; Kidney; Uric acid

Indexed keywords

ADENINE; CREATININE; CRYOPYRIN; GLIBENCLAMIDE; HEME OXYGENASE 1; NITROGEN; TUMOR NECROSIS FACTOR ALPHA; UREA; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR PARAMETERS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MODEL; DRUG ACTIVITY; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART STRUCTURE; HEART VENTRICLE HYPERTROPHY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY STRUCTURE; LEFT VENTRICULAR STIFFNESS; MALE; NEPHRITIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; PROTEINURIA; RAT; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADENINE; GLIBENCLAMIDE; KIDNEY; URIC ACID;

ADENINE; ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; DIET; GLYBURIDE; HEART; HEME OXYGENASE (DECYCLIZING); KIDNEY; MALE; MYOCARDIUM; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RENAL INSUFFICIENCY, CHRONIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84890680545     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2013.11.007     Document Type: Article

References (36)

1. C. Zoja, P.B. Garcia, and G. Remuzzi The role of chemokines in progressive renal disease Front Biosci 14 2009 1815 1822
2. K. Turkmen, H.Z. Tonbul, A. Toker, A. Gaipov, F.M. Erdur, and H. Cicekler The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients Ren Fail 34 2012 1229 1237
3. H.J. Anders, and D.A. Muruve The inflammasomes in kidney disease J Am Soc Nephrol 22 2011 1007 1018
4. A. Vilaysane, J. Chun, M.E. Seamone, W. Wang, R. Chin, and S. Hirota The NLRP3 inflammasome promotes renal inflammation and contributes to CKD J Am Soc Nephrol 21 2010 1732 1744
5. C. Bryant, and K.A. Fitzgerald Molecular mechanisms involved in inflammasome activation Trends Cell Biol 19 2009 455 464
6. C. Ruggiero, A. Cherubini, A. Ble, A.J. Bos, M. Maggio, and V.D. Dixit Uric acid and inflammatory markers Eur Heart J 27 2006 1174 1181
7. Q.H. Hu, X. Zhang, Y. Pan, Y.C. Li, and L.D. Kong Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats Biochem Pharmacol 84 2012 113 125
8. M.J. Mulla, K. Myrtolli, J. Potter, C. Boeras, P.B. Kavathas, and A.K. Sfakianaki Uric acid induces trophoblast IL-1beta production via the inflammasome: implications for the pathogenesis of preeclampsia Am J Reprod Immunol 65 2011 542 548
9. D.M. Abdallah, N.N. Nassar, and R.M. Abd-El-Salam Glibenclamide ameliorates ischemia-reperfusion injury via modulating oxidative stress and inflammatory mediators in the rat hippocampus Brain Res 1385 2011 257 262
10. K. Pompermayer, D.G. Souza, G.G. Lara, K.D. Silveira, G.D. Cassali, and A.A. Andrade The ATP-sensitive potassium channel blocker glibenclamide prevents renal ischemia/reperfusion injury in rats Kidney Int 67 2005 1785 1796 (Pubitemid 40577713)
11. M. Lamkanfi, J.L. Mueller, A.C. Vitari, S. Misaghi, A. Fedorova, and K. Deshayes Glyburide inhibits the cryopyrin/Nalp3 inflammasome J Cell Biol 187 2009 61 70
12. T. Yokozawa, P.D. Zheng, H. Oura, and F. Koizumi Animal model of adenine-induced chronic renal failure in rats Nephron 44 1986 230 234 (Pubitemid 16002549)
13. V. Diwan, A. Mistry, G. Gobe, and L. Brown Adenine-induced chronic kidney and cardiovascular damage in rats J Pharmacol Toxicol Methods 68 2013 197 207
14. Y. Ye, Y. Lin, J.R. Perez-Polo, and Y. Birnbaum Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone Cardiovasc Drugs Ther 22 2008 429 436
15. B.M. Peskar, K. Ehrlich, and B.A. Peskar Role of ATP-sensitive potassium channels in prostaglandin-mediated gastroprotection in the rat J Pharmacol Exp Ther 301 2002 969 974 (Pubitemid 34595087)
16. V. Kumar, D. Ahmed, P.S. Gupta, F. Anwar, and M. Mujeeb Anti-diabetic, anti-oxidant and anti-hyperlipidemic activities of Melastoma malabathricum Linn. leaves in streptozotocin induced diabetic rats BMC Complement Altern Med 13 2013 222
17. S.K. Panchal, H. Poudyal, A. Iyer, R. Nazer, M.A. Alam, and V. Diwan High-carbohydrate, high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats J Cardiovasc Pharmacol 57 2011 611 624
18. L. Brown, A. Fenning, V. Chan, D. Loch, K. Wilson, and B. Anderson Echocardiographic assessment of cardiac structure and function in rats Heart Lung Circ 11 2002 167 173 (Pubitemid 36040767)
19. K. Wojcikowski, H. Wohlmuth, D.W. Johnson, and G. Gobe Dioscorea villosa (wild yam) induces chronic kidney injury via pro-fibrotic pathways Food Chem Toxicol 46 2008 3122 3131
20. A.D. Rule, and J.C. Lieske The estimated glomerular filtration rate as a test for chronic kidney disease: problems and solutions Cleve Clin J Med 78 2011 186 188
21. J.K. Dowling, and L.A. O'Neill Biochemical regulation of the inflammasome Crit Rev Biochem Mol Biol 47 2012 424 443
22. F. Martinon, V. Petrilli, A. Mayor, A. Tardivel, and J. Tschopp Gout-associated uric acid crystals activate the NALP3 inflammasome Nature 440 2006 237 241 (Pubitemid 43372104)
23. R.C. Coll, and L.A. O'Neill The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes PLoS ONE 6 2011 e29539
24. J. Tschopp, and K. Schroder NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production Nat Rev Immunol 10 2010 210 215
25. J. Melin, O. Hellberg, E. Larsson, L. Zezina, and B.C. Fellstrom Protective effect of insulin on ischemic renal injury in diabetes mellitus Kidney Int 61 2002 1383 1392 (Pubitemid 34304499)
26. J.M. Egan, C.M. Asplin, M.A. Drumheller, J.R. Kerrigan, J. Scott, and P.M. Martha Jr. Glucose-stimulated insulin release by individual pancreatic beta cells: potentiation by glyburide Proc Soc Exp Biol Med 196 1991 203 209
27. R.S. Katz, and D.H. Baker Methionine toxicity in the chick: nutritional and metabolic implications J Nutr 105 1975 1168 1175
28. D.H. Akbar, M.M. Hagras, H.A. Amin, and O.A. Khorshid Comparison between the effect of glibenclamide and captopril on experimentally induced diabetic nephropathy in rats J Renin Angiotensin Aldosterone Syst 14 2013 103 115
29. S.I. Al-Azzam, K.K. Abdul-Razzak, and M.W. Jaradat The nephroprotective effects of pioglitazone and glibenclamide against gentamicin-induced nephrotoxicity in rats: a comparative study J Chemother 22 2010 88 91
30. E.C. Samouilidou, A.P. Karpouza, V. Kostopoulos, T. Bakirtzi, K. Pantelias, and D. Petras Lipid abnormalities and oxidized LDL in chronic kidney disease patients on hemodialysis and peritoneal dialysis Ren Fail 34 2012 160 164
31. S. Koren, L. Shemesh-Bar, A. Tirosh, R.K. Peleg, S. Berman, and R.A. Hamad The effect of sitagliptin versus glibenclamide on arterial stiffness, blood pressure, lipids, and inflammation in type 2 diabetes mellitus patients Diabetes Technol Ther 14 2012 561 567
32. K. Takami, N. Takeda, K. Nakashima, R. Takami, M. Hayashi, and S. Ozeki Effects of dietary treatment alone or diet with voglibose or glyburide on abdominal adipose tissue and metabolic abnormalities in patients with newly diagnosed type 2 diabetes Diabetes Care 25 2002 658 662 (Pubitemid 41071183)
33. Y. Yin, Y. Yan, X. Jiang, J. Mai, N.C. Chen, and H. Wang Inflammasomes are differentially expressed in cardiovascular and other tissues Int J Immunopathol Pharmacol 22 2009 311 322
34. B. Egan, and G. Grassi Sympathetic activation and endothelial dysfunction as therapeutic targets in obesity-related hypertension J Hypertens 31 2013 259 260
35. M.H. Alderman Uric acid and cardiovascular risk Curr Opin Pharmacol 2 2002 126 130 (Pubitemid 34296441)
36. J. Krepinsky, A.J. Ingram, and C.M. Clase Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease Am J Kidney Dis 35 2000 500 505